Supreme Court Asked to Reinstate Mail-Order Access to Abortion Pill Mifepristone 
Anthropic’s $1.5B AI Venture with Wall Street Firms Targets Private Equity Market 
Standard Chartered Q1 Profit Hits Record on Wealth and Investment Banking Growth 
Middle East Conflict Impacts Australia and New Zealand Businesses 
Coles Group Q3 Sales Rise Driven by Supermarkets and E-Commerce Growth 
Qualcomm Stock Surges Despite Weak Guidance After Q2 2026 Earnings Beat 
Berkshire Hathaway Meeting Sees Shift as Greg Abel Steps Into Leadership Spotlight 
NAB First-Half Earnings Miss Forecasts Amid Rising Global Risks 
U.S. Cybersecurity Pushes Faster Patch Deadlines Amid Rising AI-Driven Threats 
Amazon Stock Dips Despite Record Earnings as AI Infrastructure Spending Surges 
Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours 
GameStop Eyes eBay Acquisition as Stock Prices Surge After Hours 
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List 
Starbucks Raises 2026 Outlook as Turnaround Strategy Boosts Sales and Earnings 
Apple Q2 2026 Earnings Surge as iPhone 17 Sales Drive Record Revenue 
Ford Q1 Earnings Beat Expectations, Stock Surges on Strong Guidance 
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 
RADNOR, Pa., May 06, 2018 -- Kaskela Law LLC announces that a shareholder class action lawsuit has been filed against Molina Healthcare, Inc. (NYSE:MOH) (“Molina” or the “Company”) on behalf of purchasers of the Company’s securities between October 31, 2014 and August 2, 2017, inclusive (the “Class Period”).
Molina investors are encouraged to visit www.kaskelalaw.com/case/molina to receive additional information about this action and submit their information online. Investors may also contact attorney D. Seamus Kaskela at (888) 715 – 1740, or via email at [email protected], to discuss their legal rights and options with respect to this action.
The shareholder class action complaint alleges that Molina and certain of its executive officers misled investors about the scalability of the Company’s existing administrative infrastructure, and falsely claimed that the Company’s administrative infrastructure could support rapid growth into existing Medicaid markets and new Patient Protection and Affordable Care Act health insurance marketplaces in a cost-effective manner.
As detailed in the complaint, the truth about Molina’s failed growth strategy and inadequate administrative infrastructure was revealed through a series of partial disclosures, including the Company’s announcement of a major restructuring plan, and the reporting of disappointing financial results and significant restructuring costs and impairment losses. The complaint further alleges that, as a result of the foregoing, investors purchased Molina’s securities at artificially inflated prices during the Class Period and sustained significant investment losses when the truth was revealed.
Investors who purchased Molina securities during the Class Period may, no later than June 29, 2018, seek to be appointed as a lead plaintiff representative of the class through Kaskela Law or other counsel, or may choose to do nothing and remain an absent class member. In order to be appointed as a lead plaintiff a class member meet certain legal requirements.
Kaskela Law LLC exclusively prosecutes shareholder actions in state and federal courts throughout the country on behalf of investors. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
201 King of Prussia Road
Suite 650
Radnor, PA 19087
(888) 715 – 1740
[email protected]
www.kaskelalaw.com
